CARD8 Inflammasome Activation by HIV-1 Protease.
CARD8 inflammasome
Caspase-1 (CASP1)
HIV-1
Protease
Pyroptosis
Journal
Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969
Informations de publication
Date de publication:
2023
2023
Historique:
medline:
21
4
2023
pubmed:
19
4
2023
entrez:
19
04
2023
Statut:
ppublish
Résumé
The pattern recognition receptor CARD8 is an inflammasome sensor for intracellular HIV-1 protease activity. Previously, the only method for studying the CARD8 inflammasome has been through utilizing DPP8/DPP9 inhibitors including Val-boroPro (VbP) to modestly and nonspecifically activate the CARD8 inflammasome. The identification of HIV-1 protease as a target for sensing by CARD8 has opened the door for a new method of studying the underlying mechanism of CARD8 inflammasome activation. Additionally, triggering the CARD8 inflammasome offers a promising strategy for reducing HIV-1 latent reservoirs. Here we describe the methods to study CARD8 sensing of HIV-1 protease activity through non-nucleoside reverse transcriptase inhibitor (NNRTI)-mediated pyroptosis of HIV-1-infected immune cells and through an HIV and CARD8 co-transfection model.
Identifiants
pubmed: 37074642
doi: 10.1007/978-1-0716-3040-2_6
doi:
Substances chimiques
Inflammasomes
0
CARD Signaling Adaptor Proteins
0
p16 protease, Human immunodeficiency virus 1
EC 3.4.23.-
Apoptosis Regulatory Proteins
0
HIV Protease
EC 3.4.23.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
67-79Informations de copyright
© 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-1β. Mol Cell 10:417–426. https://doi.org/10.1016/s1097-2765(02)00599-3
doi: 10.1016/s1097-2765(02)00599-3
pubmed: 12191486
Broz P, Dixit VM (2016) Inflammasomes: mechanism of assembly, regulation and signaling. Nat Rev Immunol 16:407–420. https://doi.org/10.1038/nri.2016.58
doi: 10.1038/nri.2016.58
pubmed: 27291964
Gross O, Thomas CJ, Guarda G, Tschopp J (2011) The inflammasome: an integrated view. Immunol Rev 243:136–151. https://doi.org/10.1111/j.1600-065x.2011.01046.x
doi: 10.1111/j.1600-065x.2011.01046.x
pubmed: 21884173
Johnson DC, Okondo MC, Orth EL, Rao SD, Huang HC, Ball DP, Bachovchin DA (2020) DPP8/9 inhibitors activate the CARD8 inflammasome in resting lymphocytes. Cell Death Dis 11(628):628. https://doi.org/10.1038/s41419-020-02865-4
doi: 10.1038/s41419-020-02865-4
pubmed: 32796818
pmcid: 7428001
Linder A, Bauernfried S, Cheng Y, Albanese M, Jung C, Keppler OT, Hornung V (2020) CARD8 inflammasome activation triggers pyroptosis in human T cells. EMBO J 39(19):e105071. https://doi.org/10.15252/embj.2020105071
doi: 10.15252/embj.2020105071
pubmed: 32840892
pmcid: 7527815
Okondo MC, Johnson DC, Sridharan R, Bin Go E, Chui AJ, Wang MS, Poplawski SE, Wu Y, Liu Y, Lai JH, Sanford DG, Arciprete MO, Golub TR, Bachovchin WW, Bachovchin DA (2017) DPP8/9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis. Nat Chem Biol 13(1):46–53. https://doi.org/10.1038/nchembio.2229
doi: 10.1038/nchembio.2229
pubmed: 27820798
D'Osualdo A, Weichenberger CX, Wagner RN, Godzik A, Wooley J, Reed JC (2011) CARD8 and NLRP1 undergo autoproteolytic processing through a ZU5-like domain. PLoS One 6(11):e27396. https://doi.org/10.1371/journal.pone.0027396
doi: 10.1371/journal.pone.0027396
pubmed: 22087307
pmcid: 3210808
Wang Q, Gao H, Clark KM, Shema Mugisha C, Davis K, Tang JP, Harlan GH, DeSelm CJ, Presti RM, Kutluay SB, Shan L (2021) CARD8 is an inflammasome sensor for HIV-1 protease activity. Science 371(6535):eabe1707. https://doi.org/10.1126/science.abe1707
doi: 10.1126/science.abe1707
pubmed: 33542150
pmcid: 8029496
Sharif H, Hollingsworth LR, Griswold AR, Hsiao JC, Wang Q, Bachovchin DA, Wu H (2021) Dipeptidyl peptidase 9 sets a threshold for CARD8 inflammasome formation by sequestering its active C-terminal fragment. Immunity 54(7):1392–1404. https://doi.org/10.1016/j.immuni.2021.04.024
doi: 10.1016/j.immuni.2021.04.024
pubmed: 34019797
pmcid: 8423358
Figueiredo A, Moore KL, Mak J, Sluis-Cremer N, de Bethune MP, Tachedjian G (2006) Potent nonnucleoside reverse transcriptase inhibitors target HIV-1 gag-pol. PLoS Pathog 2(11):e119. https://doi.org/10.1371/journal.ppat.0020119
doi: 10.1371/journal.ppat.0020119
pubmed: 17096588
pmcid: 1635531
Jochmans D, Anders M, Keuleers I, Smeulders L, Kräusslich HG, Kraus G, Müller B (2010) Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease. Retrovirology 7:89. https://doi.org/10.1186/1742-4690-7-89
doi: 10.1186/1742-4690-7-89
pubmed: 20950436
pmcid: 2974656
Zerbato JM, Tachedjian G, Sluis-Cremer N (2017) Nonnucleoside reverse transcriptase inhibitors reduce HIV-1 production from latently infected resting CD4. Antimicrob Agents Chemother 61(3):e01736. https://doi.org/10.1128/aac.01736-16
doi: 10.1128/aac.01736-16
pubmed: 27993846
pmcid: 5328526
Mochizuki H, Schwartz JP, Tanaka K, Brady RO, Reiser J (1998) High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J Virol 72(11):8873. https://doi.org/10.1128/JVI.72.11.8873-8883.1998
doi: 10.1128/JVI.72.11.8873-8883.1998
pubmed: 9765432
pmcid: 110304